Santa Monica Cancer Conference
November 24th 2024
The Huntley Hotel
Santa Monica Beach
1111 2nd St,
Santa Monica, CA 90401
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
5th Annual Santa Monica Cancer Conference
A multidisciplinary discussion of the most recent advances in the treatment of breast and prostate cancer.
Relevant Topics Include: Advances in chemotherapy, immunotherapy, radioligand therapy, integration of AI in cancer treatment, and antibody drug conjugates
Program Directors:
Mark Pegram, M.D.
Thomas J. Lomis, M.D.
Nicholas McAndrew, M.D.
Program Agenda
Breakfast
7:30am
Recent advances and emerging strategies for the medical treatment of breast cancer
8am
Mark Pegram, M.D.
Integrating innovations in radioligand therapies into clinical practice
8:30am
Frankis Almaguel, M.D., PhD
Neoadjuvant trastuzumab deruxtecan in early stage Her2 low, estrogen positive breast cancer: Updates from an investigator initiated trial
9am
Nicholas McAndrew, M.D., MSCE
Break
9:30am
Immunotherapy in Breast Cancer - targeting Supprepression to improve response
9:45am
Evanthia Roussos Torres, M.D., Ph.D
Focal therapy for prostate cancer: an update
10:15am
Amir H. Lebastchi, M.D.
Improved Diagnostic Imaging for Metastasis-Directed Therapy and Theranostics
10:45am
Steven P. Rowe, M.D., Ph.D
Lunch
9:30am
Development of the PhosAm pH-responsive linker system and application in targeted delivery and controlled release
11:30am
Cliff Berkman, Ph.D
New Approaches for Targeted Delivery of Theranostics
1pm
Saman Sadeghi, Ph.D.
Novel antibody drug conjugates targeting claudin 6 and claudin 18.2
1:30pm
Dennis Slamon, M.D., Ph.D.
Prognostic and predictive biomakers in breast and prostate cancers
2pm
Kai Treuner, Ph.D
AI in prostate cancer: where we are todayMihir M Desai, M.D., MPH, FRCS
2:30pm
Mihir M Desai, M.D., MPH, FRCS
Break
3pm
Active Surveillance for prostate cancer: State of the art
3:20pm
Cristopher Filson, M.D., MS
TBD
3:50pm
Mark Pegram, M.D.
Hors d'oeuvres and cocktail reception
4:20pm
Faculty
Amir H. Lebastchi, MD
Assistant Professor of Clinical Urology
University of Southern California
Cliff Berkman, Ph.D
Professor and ChairDept. of Chemistry
Washington State University
Mihir M Desai, M.D., MPH, FRCS (Galsg.)
The Dua Family Professor of Urologic Oncology
Vice- Chair innovation Director of Robotic Surgery Chair, Department of Urology Research Council
University of Southern California
Christopher P. Filson, M.D., MS
Clinical Assistant Professor
Kaiser Permanente Los Angeles Medical Center
Thomas J. Lomis, M.D.
Surgical Oncologist Medical Director of
San Fernando Valley Cancer Center
Nicholas McAndrew, M.D., MSCE
Assistant Professor Devision of Hematology Oncology
UCLA David Geffen School of Medicine
Mark Pegram, M.D.
Professor of Medical Oncology
Stanford Medical School
Steven P. Rowe, M.D., Ph.D
Professor of Radiology Division Chief,
Molecular Imaging and Therapeutics Medical Director,
Biomedical Research Imaging Center
Evanthia Roussos Torres, M.D., Ph.D
Assistant Professor of Medicine,
Division of Oncology Co-Leader Tumor Immune Microenvironment Program
University of Southern California
Saman Sadeghi, Ph.D
Associate Professor Department of Chemistry &
Chemical Biology
McMaster University
Adjunct Associate Professor
Department of Molecular and Medical Pharmacology
David Geffen School of Medicine at UCLA
Dennis Slamon, M.D., Ph.D
Department of Medicine/Division of Hematology-Oncology
UCLA Translational Oncology Research Laboratory (TORL)
Kai Treuner, Ph.D
Sr. Director Oncology Diagnostics
Biotheranostics, Inc.